UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000015961 |
|---|---|
| Receipt number | R000018565 |
| Scientific Title | A Study about Periodic Cooperation Program for Chronic Kidney Disease between Primary Care Physicians and Kidney Specialists |
| Date of disclosure of the study information | 2015/10/01 |
| Last modified on | 2015/07/24 10:05:53 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
A Study about Periodic Cooperation Program for Chronic Kidney Disease between Primary Care Physicians and Kidney Specialists
Acronym
Utility of Periodic Cooperation Program for Chronic Kidney Disease
Scientific Title
A Study about Periodic Cooperation Program for Chronic Kidney Disease between Primary Care Physicians and Kidney Specialists
Scientific Title:Acronym
Utility of Periodic Cooperation Program for Chronic Kidney Disease
Region
| Japan |
Condition
Condition
Chronic Kidney Disease
Classification by specialty
| Nephrology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
No reports have explored the utility of periodic cooperation program for chronic kidney disease between primary care physicians and kidney specialists using a team approach. We therefore retrospectively examine the utility of our periodic cooperation program.
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Estimated glomerular filtration rate, home blood pressure
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| Not applicable |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1 Patients who had a diagnosis of chronic renal disease
2 Patients who received a nutrition education
3 Patients who measure home blood pressure
4 Patients who visit our hospital regularly for the cooperation program between primary care physicians and kidney specialists
5 Patients who do urine and a blood test for every cooperation in our hospital
Key exclusion criteria
1 Patients who judged to be inadequate as analysis subject by a physician
Target sample size
120
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Kazuyoshi Okada |
Organization
Nihon University School of Medicine
Division name
Division of Nephrology, Hypertension and Endcrinology
Zip code
Address
30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo, Japan
TEL
03-3972-8111
kokada@med.nihon-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Kimitoshi kato |
Organization
Nihon University School of Medicine
Division name
Clinical research center
Zip code
Address
30-1 Oyaguchi-kamicho, Itabashi-ku, Tokyo, Japan
TEL
3972-8111
Homepage URL
kimitoshi.kato@nihon-u.ac.jp
Sponsor or person
Institute
Division of Nephrology, Hypertension and Endcrinology, Nihon University School of Medicine
Institute
Department
Personal name
Funding Source
Organization
Division of Nephrology, Hypertension and Endcrinology, Nihon University School of Medicine
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2015 | Year | 10 | Month | 01 | Day |
Related information
URL releasing protocol
Publication of results
Partially published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2014 | Year | 12 | Month | 16 | Day |
Date of IRB
Anticipated trial start date
| 2015 | Year | 02 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
We investigate the following items.
1 Patients information from letter of introduction and the an interview: age, sex, diagnosis, a medical history, prescription contents
2 Urine and blood tests: urinary protein excretion rate, urinary alubumin excretion rate, serum creatinine, estimated glomerular filtration rate, hemoglobin A1c, LDL-cholesterol, HDL-cholesterol, triglyceride, non-HDL cholesterol, uric acid, potassium, hemoglobin, calcium in case with prescription of vitamin D or calcium-containing agent, iron, unbound iron binding capacity, and ferritin in case with anemia
3 blood pressure at consulting room and home
4 Imaging studies: abdominal echography, ultrasonography of carotid artery, ultrasonic cardiography, head MRI and other imaging studies if needed
5 Others: Prescription contents for change, practice period, periodic visit rate for cooperation
Management information
Registered date
| 2014 | Year | 12 | Month | 15 | Day |
Last modified on
| 2015 | Year | 07 | Month | 24 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018565
